Author

Santiago Foos-Russ

Kyverna Therapeutics, Inc. (United States)ORCID 0009-0001-0421-9857Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Santiago Foos-Russ1 paper · University of Miami

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Ames C. RegisteriD· 1 shared Brandon KwongiD· 1 shared Candice Gibson· 1 shared Daniel Anaya· 1 shared Jazmin Bravo· 1 shared Jeanne Flandez· 1 shared Jeevitha Jeevan· 1 shared Jennifer Zeng· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Ames C. RegisterORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivPreprintJan 24, 2024

Development of Ingenui-T, a Novel Vein-to-Vein Solution for Rapid Autologous CAR T-Cell Manufacturing Starting From Whole Blood, for the Treatment of Autoimmune Diseases

Daniel Anaya, Brandon Kwong, Soo Park…·Karen Walker

This paper introduces Ingenui-T, a method for rapid CAR T-cell manufacturing from whole blood, showing comparable or better functional activity than conventional methods.

5 citations

humanproteomics

𝕏 PostBluesky